About Bikramjit Singh
Form D filings for Nivagen Pharmaceuticals in 2020 list Bikramjit Singh as director.
Bikramjit Singh first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Bikramjit Singh in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Bikramjit Singh works with at each company, as listed on that company's latest Form D.
Nivagen Pharmaceuticals, Inc. · Form D, May 20, 2020
JM
Jaswinder Matharu
Director
AS
Ashish Sevak
Director
RH
Rob Hart
Director
JS
Jwalant Shukla
President and director